Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
06/2008
06/19/2008US20080142764 Conductive nanocomposite films
06/19/2008US20080142084 Solution-based fabrication of photovoltaic cell
06/19/2008US20080142083 Solution-based fabrication of photovoltaic cell
06/19/2008US20080142082 Forming active material of copper/indium/gallium/selenium or sulfur as ink for solar cells by reacting a solution of non-oxide compounds and capping agent; annealing to form nanoparticles 1-500nm diameter; narrow size distribution; close packing; uniformity; polycrystalline; quality; high quality films
06/19/2008US20080142081 Solution-based fabrication of photovoltaic cell
06/19/2008US20080142080 Forming active material of copper/indium/gallium/selenium or sulfur as ink for solar cells by reacting a solution of non-oxide compounds and capping agent; annealing to form nanoparticles 1-500nm diameter; narrow size distribution; close packing; uniformity; polycrystalline; quality; high quality films
06/19/2008US20080142072 Solution-based fabrication of photovoltaic cell
06/19/2008DE102006059510A1 Beschichtete Pellets Coated pellets
06/19/2008DE102006059240A1 Rod for applying active agent and for disinfection, cleaning and caring of area of piercing holes, has two end sections, which are adjacent to middle section
06/19/2008DE102006058253A1 Microcapsule, useful as accumulator for materials e.g. in industrial processes, comprises a capsule core, which contains a gelable matrix substance and filler, which forms a porous structure in which free-release material is present
06/19/2008CA2673234A1 Linker-based lecithin microemulsion delivery vehicles
06/19/2008CA2673111A1 Ph sensitive matrix formulation
06/19/2008CA2672529A1 Porous keratin construct and method of making the same
06/19/2008CA2672496A1 Medical implants with a combination of compounds
06/19/2008CA2672495A1 Novel injectable chitosan mixtures forming hydrogels
06/19/2008CA2672338A1 Archaeal polar lipid aggregates for administration to animals
06/19/2008CA2672226A1 Anti-inflammatory compounds containing compositions for treatment of cancer
06/19/2008CA2672157A1 Method for producing solid preparation
06/19/2008CA2672154A1 Pharmaceutical composition having improved storage stability
06/19/2008CA2672153A1 Polyphenol containing compositions
06/19/2008CA2672134A1 Solid medicinal preparation containing mannitol or lactose
06/19/2008CA2671979A1 Pharmaceutical composition containing low-substituted hydroxypropyl cellulose
06/19/2008CA2671968A1 Abeta antibody parenteral formulation
06/19/2008CA2671775A1 An article comprising prasugrel
06/19/2008CA2671495A1 Microemulsion dosage forms of valsartan and methods of making the same
06/19/2008CA2671469A1 Oral contraceptive spray
06/19/2008CA2668576A1 Ocular devices and methods of making and using thereof
06/19/2008CA2571906A1 Cold-preparable, low-viscosity and prolonged-stability cosmetic emulsions
06/18/2008EP1932870A1 Biocompatible block copolymer, use thereof, and production method thereof
06/18/2008EP1932532A1 Dieting composition comprising plant-derived essential oil as active ingredient, sheet-type dieting composition comprising the composition, transdermal pharmaceutical preparation for dieting, and methods for production of the preparation
06/18/2008EP1932523A1 Adhesive preparation containing bisoprolol
06/18/2008EP1932519A1 Protein stabilization formulations
06/18/2008EP1932518A1 Statin containing compositions for treatment of cancer
06/18/2008EP1932517A2 Liposomes containing a polyphenol derivative such as caffeic acid and a method of post-loading thereof
06/18/2008EP1932516A1 Anti-inflammatory compounds containing compositions for treatment of cancer
06/18/2008EP1931388A2 Methods for treatment and prevention of otitis media using nonionic surfactants to facilitate transmembrane drug delivery into the middle ear
06/18/2008EP1931387A2 Biodegradable microparticle pharmaceutical formulations exhibiting improved release rates
06/18/2008EP1931365A2 Fiber satiety compositions
06/18/2008EP1931361A2 Nanosized carotenoid cyclodextrin complexes
06/18/2008EP1931346A2 Trazodone composition for once a day adminisitiation
06/18/2008EP1931340A2 Nanoparticulate azelnidipine formulations
06/18/2008EP1931338A1 Aerosol powder formulation comprising sieved lactose
06/18/2008EP1931325A2 Octanol formulations and methods of treatment using the same
06/18/2008EP1931323A2 Formulations and methods for enhancing the transdermal penetration of a drug
06/18/2008EP1931321A2 Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
06/18/2008EP1931320A2 Microparticles with modified release of at least one active principle and oral galenic form comprising same
06/18/2008EP1931319A2 Satiety
06/18/2008EP1931318A1 Liquid filled delivery system, preferably an hpmc capsule filled with glycerol
06/18/2008EP1931317A2 Pancreatin micropellet cores suitable for enteric coating
06/18/2008EP1931316A2 Controlled release pharmaceutical compositions for acid labile drugs
06/18/2008EP1931315A2 Sustained release formulations of nalbuphine
06/18/2008EP1931314A2 Ramipril formulation
06/18/2008EP1931313A2 Methods of preparing polymers having terminal amine groups using protected amine salts
06/18/2008EP1931312A2 Ion exchange resin treated to control swelling
06/18/2008EP1931311A1 Polysaccharide microparticles containing biological agents: there preparation and applications
06/18/2008EP1931310A2 Topical formulations
06/18/2008EP1931309A2 Antifungal composition
06/18/2008EP1931308A2 Gelling hydrophobic injectable polymer compositions
06/18/2008EP1931307A1 Fiber satiety compositions
06/18/2008EP1931306A1 Non-protein stabilized clostridial toxin pharmaceutical compositions
06/18/2008EP1931305A2 Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
06/18/2008EP1931304A1 New use for a composition comprising chloroprocaine hcl, a new composition comprising chloroprocaine hcl and a method for its manufacture
06/18/2008EP1931222A2 Gelling compositions and methods
06/18/2008EP1804764B1 Manufacturing of a rapidly disintegrating presentation starting from a solid powder and a step of freeze drying
06/18/2008EP1799186B1 Octenidine-containing lozenges used against inflammatory oral and pharyngeal diseases
06/18/2008EP1638534B1 Use of ethanol as plasticizer for preparing subcutaneous implants containing thermolabile active principles dispersed in a plga matrix
06/18/2008EP1585470A4 Transdermal delivery of fentanyl
06/18/2008EP1494656B1 Analgesic oral composition with controlled release of an opioid
06/18/2008EP1487418B1 Co-beadlet of dha and rosemary and methods of use
06/18/2008EP1478348A4 Microinfusion device
06/18/2008EP1443968B1 Edible film
06/18/2008EP1418922B1 Use of negatively charched phospholipids for the preparation of a medicament for treatment and/or prevention of macular degeneration
06/18/2008EP1372708B1 Vaccine for transcutaneous immunization against travellers' diarrhoea
06/18/2008EP0918541B9 Immunstimulating lipid formulation
06/18/2008CN101203553A Porous cellulose aggregate and molding composition thereof
06/18/2008CN101203246A Medical composition
06/18/2008CN101203245A Injection solution for RNA
06/18/2008CN101203236A Prophylactic or therapeutic agent for conrneal/conjunctival disease
06/18/2008CN101203235A Stable pharmaceutical compositions including motilin-like peptides
06/18/2008CN101203223A Pharmaceutical composition comprising amorphous rosiglitazone
06/18/2008CN101203213A Gellan seamless breakable capsule and process for manufacturing thereof
06/18/2008CN101203212A Inhalator capsules
06/18/2008CN101203211A Pharmaceutical composition
06/18/2008CN101203210A Water soluble analgesic formulations and methods for production
06/18/2008CN101203209A Topical ungual formulations
06/18/2008CN101203208A Dronabinol treatment for migraines
06/18/2008CN101203138A Oral cavity delivering system for managing release
06/18/2008CN101200488A Novel biogastrone acid derivatives, preparation method and medical uses thereof
06/18/2008CN101200438A Novel water-soluble azulene derivatives, preparation method and medical composition thereof
06/18/2008CN101199855A Skinniness hormone packing matter water solution and application thereof
06/18/2008CN101199854A Stomach dissolved film coating pre-mix dose and preparing method thereof
06/18/2008CN101199853A Bloodvesselofbrain endodermis cell target polylactic acid nanometer particle carrier, producing method and application thereof
06/18/2008CN101199851A Preparing method of lyophilized powder injection via high solid amount mannite accessory
06/18/2008CN101199849A Compound for medicine containing nucleoside (acid) and plant extract, preparing method and function thereof
06/18/2008CN101199848A Drug compound for Ca channel retarder/diuretic/ folate coupling and function
06/18/2008CN101199847A Drug compound for AT1 receptor antagonist/diuretic/folate coupling and uses thereof
06/18/2008CN101199845A Stable anti-IgE humanized single anti-agent
06/18/2008CN101199844A Liquid agent of stable anti-EGFR chimeric antibody
06/18/2008CN101199842A Lactase sheet and preparing method thereof
06/18/2008CN101199841A Lactase capsule and preparing method thereof
1 ... 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 ... 2991